| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.01 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Introduction In colon cancer distinct genetic subtypes have been described, one of which involves overexpression of RAC1b, a variant
generated by alternative splicing. Aberrant splicing is known to occur in cancer and can be caused by mutation in a gene or splicing factor but
also represents a dynamic response to oncogene-induced cellular signaling and in this case it may be pharmacologically targeted. Here we
explore how signaling pathways are involved in the deregulation of alternative RAC1b splicing in colorectal tumor cells.
Description
Keywords
Vias de Transdução de Sinal e Patologias Associadas Cancro Coloretal RAC1b Splicing Alternativo
